BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. | BioNTech has shown ...
Ochsner Lafayette General Medical Center performed its first procedure with the Ion robotic-assisted bronchoscopy system; ...
The latest data from Johnson and Johnson's Rybrevant and Lazcluze lung cancer combo was better than standard of care Tagrisso ...
The 10-week course at Stanford last fall was fully enrolled and packed with students eager to learn from Dr. Lin's unique ...
The first-line combination of amivantamab-vmjw plus lazertinib extended OS compared with osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer, according to data from the ...
Lung cancer screening more than tripled after the U.S. Preventive Services Task Force expanded screening eligibility in 2021, according to a March 20 research letter published in JAMA Oncology. ...
Patients recovering from curative-intent lung cancer surgery with exposure to wildfire disaster have longer lengths of stay in the hospital.
SAN ANTONIO, March 26, 2025--bioAffinity Technologies' CyPath Lung test uncovered a hidden second primary lung cancer in a patient who had been treated for lung cancer earlier.
Medical robotics innovator Noah Medical today shared that the company reached a significant milestone by completing 5,000 procedures with its Galaxy Systemâ„¢ in the United States. Dr. Abhinav Agrawal ...
Providence St. Joseph Hospital in Eureka is proud to announce the successful implementation of its ion robotic bronchoscopy program, which has already demonstrated remarkable results in diagnosing ...
It invested in a robotic, noninvasive technology for biopsies of hard-to-reach lesions in the lungs and to remove suspected ...
The firm is preparing for a trial to show the efficacy of its CyPath Lung test and support a submission to the US Food and Drug Administration for marketing clearance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results